Brief: Galmed Announces Allowance Of New Patent For Aramchol For The Treatment Of Pulmonary And Dermal Fibrosis

Eocene

26/09/2023 13:38

Sept 26 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED ANNOUNCES ALLOWANCE OF NEW PATENT FOR ARAMCHOL FOR
THE
TREATMENT OF PULMONARY AND DERMAL FIBROSIS
    * GALMED PHARMACEUTICALS LTD - GALMED IS STRENGTHENING AND
EXTENDING PATENT PROTECTION OF ITS LEAD COMPOUND, ARAMCHOL,
UNTIL NOVEMBER 2037

Source text for Eikon:  ID:nPn1PwrcYa 
Further company coverage:  GLMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))